Your daughter is cupping both hands around her throat. She is crying, her mouth is open, but there is no sound. She’s unable to breathe. She stands there looking up to you, shaking, waiting for you to help. What would you do? It is a frightening question for parents and one that many are unprepared to answer.
They said it couldn’t be done. No less a genius than Leonardo da Vinci tried to design a workable airplane. He got as far as building a couple of gliders and apparently even soared off the roof of a barn for a few moments. Discouraged that he couldn’t do better, da Vinci wrote …
Resveratrol, a popular anti-inflammatory and antioxidant plant extract, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
EventsEAST BAY East Bay SPCA — “Fanciful Bunny,” 11 a.m. Aug. 7 adoptions, 4-5 p.m. art reception. Buy a work of art and adopt a bunny. 4651 Gleason Drive, Dublin.
SynCo Bio Partners today announced an extension of its successful collaboration with Versartis, Inc. following the recent initiation of a Phase 1 clinical trial in type 2 diabetes mellitus (T2DM) patients with monthly dosing of VRS-859. This news comes less than 12 months since the parties entered into a strategic partnership to manufacture Versartis’ lead product VRS-859 (exenatide-XTEN).
FAIRFIELD, Conn. — Competitive Technologies, Inc. announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT’s Calmare Pain Therapy medical device.
Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert from Rush University Medical Center were presented at the Society of Neurointerventional Surgery (SNIS) 7th annual …
Nature Reviews Clinical Oncology 7, 422 (2010). doi:10.1038/nrclinonc.2010.109
Author: Lisa Hutchinson
The antitumor efficacy of oncolytic viruses can be influenced by the immune system. Adenoviruses are among the most advanced cancer gene therapy approaches; however, despite evidence of activity of these agents in clinical trials, single-agent efficacy has been disappointing. Researchers from Helsinki generated an oncolytic (Source: Nature Clinical Practice Oncology)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Mucopolysaccharidosis (MPS) IVA is an autosomal recessive disorder caused by deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate sulfatase (GALNS), which leads to the accumulation of keratan sulfate and chondroitin 6-sulfate, mainly in bone. To explore the possibility of gene therapy for Morquio A disease, we transduced the GALNS gene into HEK293 cells, human MPS IVA fibroblasts and murine MPS IVA chondrocytes by using adeno-associated virus (AAV)-based vectors, which carry human GALNS cDNA. The effects of the promoter and the cotransduction with the sulfatase-modifying factor 1 gene (SUMF1) on GALNS activity levels was evaluated. Downregulation of the cytomegalovirus (CMV) immediate early enhancer/promoter was not observed for 10 days post-transduction. The eukaryotic promot…
Authors: W-B Pyun, W Hahn, D-S Kim, W-S Yoo, S-D Lee, J-H Won, B-S Rho, Z-Y Park, J-M Kim
& S Kim (Source: Gene Therapy)
Authors: G-J Ye, M M Scotti, J Liu, L Wang, D R Knop
& G Veres (Source: Gene Therapy)
Authors: S Peng, A Monie, T H Kang, C-F Hung, R Roden
& T-C Wu (Source: Gene Therapy)
Authors: S R Riddell
& U Protzer (Source: Gene Therapy)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Winners and losers and oncolytic adenoviruses: who should be down in the mouth?
Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.98
Author: K J Harrington (Source: Gene Therapy)
According to Microsoft Chief Operating Officer Kevin Turner, Microsoft is getting ready to roll out IE version 9 in September. As per some leaked report, Microsoft is expected to release the Beta version in August. The Beta is supposed to feature more user interfaces. The Web Developers are keenly waiting for the new browser. …. Original article on Gaea Times at : Internet Explorer 9 Beta is Due in September.
more images
3G technology is fast changing the cellular landscape of India with high-speed transmission, advanced multimedia access and worldwide roaming. With government owned mobile service provider BSNL’s 3G service India’s mobile phone market is pepped up with lightning speed 3G technology. The arrival of 3G Spectrum auction opens up a new road map for next-generation …. Original source : Top 5 Cheapest 3G Mobile Phones in India 2010.
more images
more images
Google’s 2010 shopping spree has cost $1.1B so far
MOUNTAIN VIEW, Calif. — Google Inc. has spent $1.1 billion during the first half of the year buying up 22 companies, with more than half of the amount going toward its recently completed acquisition of mobile ad service AdMob.
The financial breakdown was part of a … Original source on Gaea Times at : Google has spent $1.1 billion snapping up 22 companies through first half of year.
Dish to FCC: Comcast blocking Philly sports access
PHILADELPHIA — Dish Network Corp. said Friday it’s planning to file a complaint soon with federal regulators against Comcast Corp. for its refusal to provide access to a sports channel that airs games by the Philadelphia 76ers, Phillies and Flyers.
The satellite TV company asked Comcast last month to … Read this article on Gaea Times at : Dish Network to file complaint with FCC that Comcast is blocking access to Philly sports.
more images
more images
Motorola spent $880,000 lobbying in second quarter
WASHINGTON — Motorola Inc., the maker of cell phones and other telecommunications equipment, spent $880,000 in the first quarter to lobby the federal government on laws such as those that sought to discourage electronics manufacturers from using minerals from rebel-held mines in the Congo, according to a … Original article on : Motorola spent $880,000 in second quarter to lobby government on minerals, patents.
more images
more images
Nokia spent $150,000 on lobbying in second quarter
WASHINGTON — Nokia Inc., the world’s largest maker of cell phones, spent $150,000 in the second quarter to lobby the U.S. federal government on patents, the use of minerals from rebel-held mines in the Congo and other issues, according to a disclosure report.
That’s slightly less than … Read more »»».